| PATISIRAN SODIUM | None | ||
| 10MG/5ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ONPATTRO contains a transthyretin-directed small interfering RNA and is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. | |||
|
Yes
| |||
| ONPATTRO | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 | Patent 24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||||||
| ***** ************ *** ******* **** ******** | ***** *********** | ************ *** ******* *** ********** ********** ** ************* | ***** ************ *** ******* **** ******** | ***** ********** ************ | ************ *** ******* *** ********** ********** ** ************* | ***** *********** | ***** ************ *** ******* **** ******** | ************ *** ******* *** ********** ********** ** ************* | ***** ************ *** ******* **** ******** | ************ *** ******* *** ********** ********** ** ************* | ******* ** ******** ************* (***) ******** *********** | ***** ************ *** ******* **** ******** | *** ************ ********* ***** *** ********* | *** ************ ********* ***** *** ********* | *** ********-******** ********* ** *** ************ | *** ************ ********* ***** *** ********* | *** ************ ********* ***** *** ********* | *** ************ ********* ***** *** ********* | *** ********-******** ********* ** *** ************ | *** ************ ********* ***** *** ********* | *′-******* *********** ********** ********* *** ************ *** *** ** **** *********** | *′-******* *********** ********** ********* *** ************ *** *** ** **** *********** | ******** ********* ******-******** *********** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|